New info on #BioconBiologics intended launch of insulin glargine biosimilar, after second complete response letter… https://t.co/JWf0u0bevr
New info on #BioconBiologics intended launch of insulin glargine biosimilar, after second complete response letter… https://t.co/JWf0u0bevr